Holen Sie sich die Stockscreener-App
0.352
10.71%
-0.0422
Handel nachbörslich:
.35
-0.002
-0.57%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$0.3942
Offen:
$0.3616
24-Stunden-Volumen:
480.15K
Relative Volume:
3.75
Marktkapitalisierung:
$N/A
Einnahmen:
$80.72M
Nettoeinkommen (Verlust:
$-56.64M
KGV:
-1.408
EPS:
-0.25
Netto-Cashflow:
$-37.17M
1W Leistung:
-10.71%
1M Leistung:
+0.46%
6M Leistung:
-41.18%
1J Leistung:
-35.85%
1-Tages-Spanne:
$0.346
$0.3625
1-Wochen-Bereich:
$0.346
$0.3625
52-Wochen-Spanne:
$0.33
$0.421
Vaxart Inc Stock (VXRT) Company Profile
Vergleichen Sie VXRT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VXRT
Vaxart Inc
|
0.352 | 0 | 80.72M | -56.64M | -37.17M | -0.25 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Vaxart Inc Stock (VXRT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-08-15 | Eingeleitet | Oppenheimer | Outperform |
| 2021-12-29 | Fortgesetzt | Jefferies | Buy |
| 2021-11-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-06-29 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-06-24 | Eingeleitet | Jefferies | Buy |
| 2021-06-11 | Eingeleitet | Piper Sandler | Overweight |
| 2020-08-12 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-13 | Eingeleitet | B. Riley FBR | Buy |
Alle ansehen
Vaxart Inc Aktie (VXRT) Neueste Nachrichten
Vaxart director Heron buys $15921 in company stock By Investing.com - Investing.com Canada
Vaxart director Heron buys $15921 in company stock - Investing.com
Why Vaxart Inc. stock is in analyst buy zoneWeekly Profit Report & Weekly Breakout Opportunity Watchlist - newser.com
Will Vaxart Inc. (NB11) stock outperform energy sector in 20252025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
How strong is Vaxart Inc. stock revenue growthWeekly Investment Recap & Weekly Watchlist of Top Performers - newser.com
Is Vaxart Inc. stock attractive for retirement portfoliosJuly 2025 News Drivers & Accurate Trade Setup Notifications - newser.com
Will Vaxart Inc. (NB11) stock benefit from mergersJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - newser.com
How Vaxart Inc. stock reacts to bond yieldsDollar Strength & High Conviction Investment Ideas - newser.com
What margin trends mean for Vaxart Inc. stockWeekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Can Vaxart Inc. (NB11) stock deliver double digit returnsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Vaxart Inc Stock Analysis and ForecastOptions Trading Strategies & Superior Trading Portfolio - earlytimes.in
Will Vaxart Inc. stock see insider buyingJuly 2025 Final Week & Free Community Consensus Stock Picks - newser.com
Will Vaxart Inc. (NB11) stock test record highs in 2025July 2025 Setups & Technical Confirmation Trade Alerts - newser.com
Can Vaxart Inc. (NB11) stock resist broad market declinesQuarterly Portfolio Review & AI Powered Trade Plan Recommendations - newser.com
Can Vaxart Inc. stock rebound after recent weaknessJuly 2025 Macro Moves & Low Risk Entry Point Guides - newser.com
How Vaxart Inc. (NB11) stock benefits from digital adoptionNew Guidance & Reliable Price Breakout Alerts - newser.com
Why Vaxart Inc. (NB11) stock is a must watch tickerGold Moves & Low Drawdown Momentum Trade Ideas - newser.com
What recovery options are there for Vaxart Inc.2025 Buyback Activity & Weekly Chart Analysis and Guides - newser.com
Analyzing Vaxart Inc. with multi timeframe chartsCPI Data & Free Community Supported Trade Ideas - newser.com
Understanding Vaxart Inc.’s price movementPortfolio Value Report & Low Drawdown Investment Strategies - newser.com
Finanzdaten der Vaxart Inc-Aktie (VXRT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.88%
Kapitalisierung:
|
Volumen (24h):